Eli Lilly EPS - Earnings per Share 2006-2019 | LLY

Eli Lilly annual and quarterly earnings per share history from 2006 to 2019. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Eli Lilly EPS for the quarter ending June 30, 2019 was $1.44, a 676% decline year-over-year.
  • Eli Lilly EPS for the twelve months ending June 30, 2019 was $7.97, a 6230.77% decline year-over-year.
  • Eli Lilly 2018 annual EPS was $3.13, a 1747.37% decline from 2017.
  • Eli Lilly 2017 annual EPS was $-0.19, a 107.36% decline from 2016.
  • Eli Lilly 2016 annual EPS was $2.58, a 14.16% increase from 2015.
Eli Lilly Annual EPS
2018 $3.13
2017 $-0.19
2016 $2.58
2015 $2.26
2014 $2.23
2013 $4.32
2012 $3.66
2011 $3.90
2010 $4.58
2009 $3.94
2008 $-1.89
2007 $2.71
2006 $2.45
2005 $1.81
Eli Lilly Quarterly EPS
Q2 2019 $1.44
Q1 2019 $4.31
Q4 2018 $1.10
Q3 2018 $1.12
Q2 2018 $-0.25
Q1 2018 $1.16
Q4 2017 $-1.57
Q3 2017 $0.53
Q2 2017 $0.95
Q1 2017 $-0.10
Q4 2016 $0.73
Q3 2016 $0.73
Q2 2016 $0.71
Q1 2016 $0.41
Q4 2015 $0.45
Q3 2015 $0.75
Q2 2015 $0.56
Q1 2015 $0.50
Q4 2014 $0.40
Q3 2014 $0.47
Q2 2014 $0.68
Q1 2014 $0.68
Q4 2013 $0.68
Q3 2013 $1.11
Q2 2013 $1.11
Q1 2013 $1.42
Q4 2012 $0.74
Q3 2012 $1.18
Q2 2012 $0.83
Q1 2012 $0.91
Q4 2011 $0.77
Q3 2011 $1.11
Q2 2011 $1.07
Q1 2011 $0.95
Q4 2010 $1.05
Q3 2010 $1.18
Q2 2010 $1.22
Q1 2010 $1.13
Q4 2009 $0.82
Q3 2009 $0.86
Q2 2009 $1.06
Q1 2009 $1.20
Q4 2008 $-3.31
Q3 2008 $-0.43
Q2 2008 $0.88
Q1 2008 $0.97
Q4 2007 $0.78
Q3 2007 $0.85
Q2 2007 $0.61
Q1 2007 $0.47
Q4 2006 $0.12
Q3 2006 $0.80
Q2 2006 $0.76
Q1 2006 $0.77
Q4 2005 $0.63
Q3 2005 $0.73
Q2 2005 $-0.23
Q1 2005 $0.68
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $106.323B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $341.878B 14.89
Roche Holding AG (RHHBY) Switzerland $235.862B 0.00
Merck (MRK) United States $210.028B 17.27
Pfizer (PFE) United States $203.709B 12.00
Novartis AG (NVS) Switzerland $197.630B 16.99
Novo Nordisk (NVO) Denmark $117.169B 20.70
AstraZeneca (AZN) United Kingdom $111.536B 21.58
Sanofi (SNY) France $109.180B 13.41
AbbVie (ABBV) United States $104.351B 8.36
GlaxoSmithKline (GSK) United Kingdom $101.265B 12.73
Bristol-Myers Squibb (BMY) United States $80.921B 11.48
Bayer (BAYRY) Germany $69.755B 10.16
H Lundbeck (HLUYY) Denmark $6.896B 9.95